semaglutide patent canada generic of approves from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 Canada Approves First Generic Semaglutide – Canada approves first generic version

Wang J, Fan S, Xiong Q, Niu Y, Zhang X, Qin J, Shi Y, Zhang L (2021) Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways

ACHIEVE-2 (NCT06192108) A comparator trial evaluating orforglipron versus dapagliflozin (an SGLT-2 inhibitor) in adults with type 2 diabetes

PS, performance status

Were onboarding new partners now, but capacity is limited, so the sooner you reach out, the sooner youre up and running with a partner built for this

Transparent Sourcing: Legitimate companies are often transparent about their ingredient sources and manufacturing processes

4K and S9A)